Related references
Note: Only part of the references are listed.Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors
Andrew Dunbar et al.
BLOOD (2021)
Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study
Joanna Roopkumar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Thromboembolism in ALK+ and ROS1+NSCLC patients: A systematic review and meta-analysis
Viola W. Zhu et al.
LUNG CANCER (2021)
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Noam Barda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Arterial Thromboembolism in Cancer Patients A Danish Population-Based Cohort Study
Frits Mulder et al.
JACC: CARDIOONCOLOGY (2021)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Association between the Khorana score and pulmonary embolism risk in patients with advanced stage lung cancer
Austeja Dapkeviciute et al.
CLINICAL RESPIRATORY JOURNAL (2020)
Impact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in NSCLC
Hanny Al-Samkari et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis
Nick van Es et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
The association between pulmonary embolism and the cancer-related genomic alterations in patients with NSCLC
Wei Xiong et al.
RESPIRATORY RESEARCH (2020)
ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events
Terry L. Ng et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH
Tzu-Fei Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Arterial thromboembolic events preceding the diagnosis of cancer in older persons
Babak B. Navi et al.
BLOOD (2019)
Retrospective Cohort Study of Venous Thromboembolism Rates in Ambulatory Cancer Patients: Association With Khorana Score and Other Risk Factors
Keziah Austin et al.
JOURNAL OF HEMATOLOGY (2019)
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)
Nicole M. Kuderer et al.
ONCOLOGIST (2018)
Association of atrial fibrillation and cancer: Analysis from two large population-based case-control studies
Walid Saliba et al.
PLOS ONE (2018)
Risk of Arterial Thromboembolism in Patients With Cancer
Babak B. Navi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study
Qian Shen et al.
JOURNAL OF THORACIC DISEASE (2017)
ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism
Alona Zer et al.
CLINICAL LUNG CANCER (2017)
Cancer associated thrombosis: risk factors and outcomes
Sabine Eichinger
THROMBOSIS RESEARCH (2016)
Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
Uwe Pelzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer
Taxiarchis V. Kourelis et al.
LUNG CANCER (2014)
Prevalence and Clinical Significance of Incidental and Clinically Suspected Venous Thromboembolism in Lung Cancer Patients
Gregory C. Connolly et al.
Clinical Lung Cancer (2013)
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
Kristin Bergethon et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas
Akihiko Yoshida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome
Bojing Shao et al.
BLOOD (2011)
Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma
Ryu Jokoji et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK
Alice T. Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With Cancer
Alok A. Khorana et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
The incidence of venous thromboembolism among patients with primary lung cancer
H. K. Chew et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
Klarisa Rikova et al.
CELL (2007)
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Share Paper
